CAPITALSTARS:- MARKET WRAP-UP

Sensex slips 139 pts, Nifty manages to hold 10,800; RIL at record close

Benchmark indices ended lower on Thursday as investors looked cautious ahead of ECB policy rate decision due later in the day after the US Federal Reserve raised interest rate by 25 basis points

The 30-share BSE Sensex declined 139.34 points to 35,599.82 and the 50-share NSE Nifty slipped 48.70 points to 10,808

TCS, Infosys, SBI, ICICI Bank, Axis Bank, Titan Company, Vedanta and L&T were under pressure while Lupin, Sun Pharma, Cipla and Coal India gained.

HEADLINES OF THE DAY

Ruchi Soya gains after co gives updates about bidding.

India May WPI rises 4.43%; Fuel price inflation at 11.22%.

ICICI Bank to sell 2% stake in life insurance arm.

The crucial resistance for Nifty spot is now seen at 10880 and above this 10960. Support for the immediate term is now placed at 10760 next support will be 10690.

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

Mcx tips,  Intraday stock tips, Financial Advisory Company

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News :- 25 Jan 2018

Top Headlines Of The Day:- 25 Jan 2018

Dr. Reddy's slumps 3% on unimpressive Oct-Dec earnings

Biocon slumps as Oct-Dec consol PAT below estimate

NCC’s Board to meet on January 30 to approve QIP issue price

Glenmark reports encouraging clinical trial data on GBR 1302

Dr. Reddy’s Bachupally plant completes successful re-inspection by German regulator

Dr. Reddy's slumps 3% on unimpressive Oct-Dec earnings
Shares of Dr. Reddy's Laboratories slumped nearly 3% as investors were unimpressed by the company's earnings for the December quarter.
The drug maker reported a consolidated net profit of Rs290cr, sharply below analysts' estimate of Rs350cr. Continued rise in pricing pressure and lack of new product launches in the US during the quarter weighed on the company's operating margin, which contracted 250bps on year to 21.2%.

Biocon slumps as Oct-Dec consol PAT below estimate
Shares of Biocon slumped over 4% after the company reported a 46.4% on-year fall in consolidated net profit for the December quarter at Rs91.9cr, below analysts' estimate.
Revenue from operations for the quarter was at Rs1058cr, against Rs1044cr a year ago. Sales in Oct-Dec were in line with estimates.

NCC’s Board to meet on January 30 to approve QIP issue price
NCC stock is up 3.3% on the back of news that the Board of Directors of NCC will meet on January 30, 2018, to consider and approve the issue price, including a discount for the equity shares to be allotted to the qualified institutional buyers in the issue.
NCC Ltd is one of the largest Indian construction companies in terms of revenue. The company’s order book was worth Rs28,109cr as of October 2017. The revenues of the company were impacted by GST implementation. We expect the company to report revenue CAGR of 3% over FY17-19E. We estimate the company’s margin to rise by 70bps on the back of cost optimization and timely execution of projects. We expect the company to report PAT CAGR of 3% over FY17-19E.

Glenmark reports encouraging clinical trial data on GBR 1302
Glenmark Pharma has reported positive clinical trial data on its phase 1 molecule GBR 1302. GBR 1302 is a potential drug candidate for Breast Cancer and Gastric Cancer.
The company has indicated that the preliminary data for GBR 1302 tells about the spikes in peripheral blood cytokines and a drop in T cell levels suggesting the potential for T cell activation.
The company has said that it is encouraged by these initial findings and look forward to continuing the studies.  GBR 1302 is Glenmark’s lead immuno-oncology agent based on the proprietary BEAT® bispecific antibody engineering platform.

Dr. Reddy’s Bachupally plant completes successful re-inspection by German regulator
Dr. Reddy’s has announced that the German drug regulator has carried out re-inspection of its Bachupally formulations plant (unit 2). The company has successfully completed this re-inspection as its subsidiary Betapharm has received a communication from the regulator that it can now start dispatching products to Europe from this plant.
The status of the EU GMP non-compliance is also to be removed from its plant by the Government of Upper Bavaria.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News:- 24 Jan 2018

Top Headlines Of The Day:- 24 Jan 2018

RBL Bank falls 4% as asset quality worsens in Oct-Dec

Ashok Leyland bags order for 1,200 trucks from VRL Logistics

Bharti Airtel gets approval for acquiring operations of Millicom in Rwanda

Eveready to form JV with Indonesia based company for FMCG products

Bank of Baroda may float $1bn QIP soon

RBL Bank falls 4% as asset quality worsens in Oct-Dec
RBL Bank stock fell over 4% after the company reported an increase in bad loans in Oct-Dec, and net profit missed estimates.
For Q3FY18, RBL Bank’s NII improved by 45% yoy to Rs467cr against Rs322cr in Q3FY17.
The NIMs for Q3FY18 stood at 3.89%, which improved by 15bps qoq. The bank’s net profit was below estimates, improvement of 27.9% yoy to Rs165cr against Rs129cr.
Its GNPA for Q3FY18 stood at 1.56% against 1.44% qoq, which has increased by 12bps. NNPA for the quarter came at 0.97% against 0.78% qoq.
The advances for the quarter came at Rs36, 890cr, up 38% yoy and 10% qoq.

Ashok Leyland bags order for 1,200 trucks from VRL Logistics
Ashok Leyland Limited (ALL), one of the largest commercial vehicle (CV) manufacturers in India, bagged an order for 1,200 trucks from VRL Logistics Limited (VRL). The order for 1,200 trucks is for two models – “AL 3123” and “AL 3723”, for 600 units each. ALL released this to the stock exchanges on January 24, 2018. The order amounts to Rs350cr. VRL is a key client for ALL since the former sources 80% of its CV requirement from the latter. 
ALL is the third largest manufacturer of commercial vehicles (trucks, buses, tippers, trailers and defence vehicles) in India with ~18% market share. The company is also engaged in the manufacturing and selling of engines for industrial and marine applications, spare parts and special alloy castings.

Bharti Airtel gets approval for acquiring operations of Millicom in Rwanda
Bharti Airtel Ltd (Airtel) a leading global telecommunications services provider with operations in 16 countries across Asia and Africa, announced that it has received an approval for the acquisition of Tigo Rwanda Ltd (Tigo Rwanda), a subsidiary of Millicom International Cellular S.A. (Millicom) from the Rwanda Utilities Regulatory Authority (RURA).
The merged entity will have the largest customer base in Rwanda with 5.9 million subscribers. The combined networks of the two companies will serve customers with voice/ data services, global roaming and mobile banking services. It will also have Rwanda’s largest sales and distribution network.
The merger will result in the only negative ebitda OpCo joining other 13 positive ebitda OpCos in Africa.

Eveready to form JV with Indonesia based company for FMCG products
India’s leading dry cell battery maker, Eveready Industries India Limited (EIIL) will form a Joint Venture (JV) with Indonesia based Universal Wellbeing Pte. Ltd. (UW) for manufacturing, importing and marketing of Fast Moving Consumer Goods (FMCG) in India. EIIL will hold 30% stake in the soon-to-be-formed JV while UW will hold the remaining 70% stake. EIIL announced this to the stock exchanges on January 24, 2018.
EIIL plans to make use of its pan-India battery distribution network to sell a bouquet of FMCG products in urban and rural areas. As per its FY17 Annual Report, EIIL has a 4,000+ distribution network and 42 distribution centers. EIIL’s products are available across more than 3.2mn outlets.

Bank of Baroda may float $1bn QIP soon
Media reports suggest that Bank of Baroda is expected to float its $1bn qualified institutional placement of shares in two to three weeks. In November, The Finance Committee of the Board approved the proposal of raising additional equity capital aggregating up to Rs6, 000cr by way of a rights issue or qualified institutions placements (QIP). This move is positive for the bank, as it would provide much-needed headroom to provide for bad loans and would also help for next leg of loan growth. The stock would react positively to this news. Banks have been raising funds in the past few months to boost their capital adequacy ratio ahead of the government's recapitalization plan.


MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News :- 23 Jan 2018

Top Headlines Of The Day:- 23 Jan 2018

ONGC gains 3%, gets nod to sell stake in IOC and GAIL to fund HPCL deal

IOCL gains as company's board to mull bonus share issue

Kalpataru Power zooms on growing order book

Torrent Pharma to consider fundraising

MCX gains 2% as SBI MF buys 1.6% stake in the company

ONGC gains 3%, gets nod to sell stake in IOC and GAIL to fund HPCL deal
Oil and Natural Gas Corporation (ONGC) signed a deal to acquire 51.11% government stake in Hindustan Petroleum Corporation Limited (HPCL).
As per media reports, ONGC has got approval from the government for selling its stake in IOC and GAIL to help fund its acquisition with HPCL for which it requires ~Rs36, 915cr.
ONGC currently holds 13.77% stake in IOC which at current Mcap values to ~Rs 26,000cr. In GAIL, it holds ~4.86% stake valuing to ~Rs3900cr bringing the combined stake sale value to ~Rs29, 900 cr.
The company is currently evaluating various options for funding its HPCL acquisition. ONGC management is considering its cash first, followed by its liquid assets, although it won’t sell its liquid assets in distress. Company also has offers over Rs50, 000cr debt at very competitive rates.

IOCL gains as company's board to mull bonus share issue
Shares of Indian Oil Corp (IOCL) gained nearly 3% ahead of its board meeting on Jan 30, where the company will consider a bonus share issue. The stock was the best performer among Nifty 50 constituents.
While a bonus share issue does not change fundamentals of a company, it increases liquidity in the stock, often pushing up share prices.

Kalpataru Power zooms on growing order book
Kalpataru Power Transmission Limited (KPTL) has secured new orders for construction of substations, transmission lines, and railway electrification
The scope of the orders include the following :
Design, supply, and construction of substations and associated transmission line work from APTRANSCO for Rs282cr
400kV double circuit transmission line from Power Grid Company of Bangladesh and an order for 132 kV Transmission Line from Nepal Electricity Authority for ~Rs100cr
Design, supply, erection, testing and commissioning of railway electrification work for Rs123cr Pipeline augmentation work in Rajasthan for Rs366cr from a private client.

Torrent Pharma to consider fundraising
Torrent Pharma has indicated that its board will consider raising funds in a meeting scheduled on January 25. This fundraising could be either in form of issuance of equity shares (including convertible/non-convertible debentures/bonds) through QIP or depository receipts or by way of private placement or any other mode.
Torrent Pharma has recently completed two acquisitions i.e. domestic formulations business of Unichem Laboratories acquired in December 2017 and US-based generic, OTC player Bio-Pharm Inc in January 2018. Both the acquisitions are to solidify its business in India and US respectively. Bio-Pharm, Inc has a USFDA registered manufacturing facility in the US and Torrent is planning to scale this facility up and start filling more products from there.

MCX gains 2% as SBI MF buys 1.6% stake in the company
Shares of Multi Commodity Exchange (MCX) rose nearly 2% today after SBI Mutual Fund bought 1.61% stake in the company through a bulk deal on the NSE on Monday. The fund house bought the shares at 840.50 rupees apiece.
In a separate deal, Barron International Growth Fund sold 1.13 mn shares or 2.2% stake in the company.
MCX is currently trading at Rs850.5, up by Rs9.35 or 1.11% from its previous closing of Rs841.15 on the BSE. The scrip opened at Rs857.05 and has touched a high and low of Rs858 and Rs847.75 respectively. So far 141378 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs4289.87cr.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News :- 22 Jan 2018

Top Headlines Of The Day:- 22 Jan 2018

Axis Bank Q3 beats estimates; profit jumps 25% to Rs 726 cr, asset quality improves

ONGC to acquire 51.11% government stake in HPCL, ONGC gains 5%

Dr. Reddy's fined $5mn by US court over drug packaging

Tata Motors hikes product prices by 1-3.7% in Mumbai

Tata Steel to raise Rs12,800cr through rights issue

Axis Bank Q3 beats estimates; profit jumps 25% to Rs 726 cr, asset quality improves
Country's third largest private sector lender Axis Bank's third-quarter earnings beat analyst expectations, with improvement in asset quality performance.
Profit during the quarter grew by 25.3 percent year-on-year to Rs 726.4 crore despite fall in other income & operating income, driven by lower provisions and higher net interest income.
Net interest income, the difference between interest earned and interest expended, grew by 9.2 percent to Rs 4,731.52 crore compared to Rs 4,333.73 crore in year-ago, with strong loan growth at 21 percent YoY.

ONGC to acquire 51.11% government stake in HPCL, ONGC gains 5%
Oil and Natural Gas Corporation (ONGC) signed a deal to acquire 51.11% stake in Hindustan Petroleum Corporation Limited (HPCL) for about Rs36,915cr in an all-cash deal, which would close by end of Jan 2018. The deal is proposed to buy 778845375 equity shares in HPCL at a cash purchase consideration of Rs473.97 per share which is ~13.8% premium to HPCL’s closing on Friday (BSE).
The goal of this deal was to create an integrated oil major to compete with global rivals and will help the government meet annual disinvestment target. The deal is exempt from a public offer as both the entities are related parties but the acquisition involving two listed entities have been carried out on an arm’s length basis.

Dr. Reddy's fined $5mn by US court over drug packaging
A federal court in the US has imposed a $5mn civil penalty on a subsidiary of Dr. Reddy’s Laboratories for distributing prescription drugs in blister packs that were not child resistant. Child-resistant packaging is a critical safety measure.
Dr. Reddy’s failed to ensure that children were protected from potentially harmful prescription drugs and that it failed to comply with Poison Prevention Packaging Act (PPPA) and the Consumer Product Safety Act (CPSA) according to the US Department of Justice. As per the complaint, Dr. Reddy’s distributed such prescription drugs until 2012 and also failed to notify the Consumer Product Safety Commission.

Tata Motors hikes product prices by 1-3.7% in Mumbai
Tata Motors Ltd (TML) has increased ex-showroom prices of all its cars by 1.0-3.7% in Mumbai. This comes after the company offered a limited-period insurance and exchange offer to its customers on five models. 
According to Cogencis, the company has raised prices of the Tiago hatchback by 1.3-2.4% for the petrol variant, and 1.7-2.6% for the diesel variant. Prices for Tiago's petrol variant now start at Rs3, 31,646 ex-showroom Mumbai, and Rs4, 11,181 for the diesel variant.
TML, on the consolidated level, derives ~80% of its revenue from a wholly owned subsidiary, JLR, which had witnessed EBITDA margin decline in FY16 and FY17 on account of weakness in volumes growth, model mix, and forex losses. Standalone business (~80% CV and PV) has experienced market share losses and is expected to turnaround the trend on account of better acceptance of SCR technology (CV) and series of new launches in PV segment (Tigor/Hexa/Tiago).

Tata Steel to raise Rs12,800cr through rights issue
Tata Steel announced that it would be raising Rs12, 800cr via a rights issue in mid-February 2018. The rights issue would consist of two simultaneous but unlinked offers of – (1) 15.54cr fully paid up shares at Rs510 per share, and (2) 7.77cr partially paid-up shares at Rs615 per share. The company would raise up to Rs8, 000cr from the first offer and Rs4, 800cr from the second offer. The rights entitlement ratio for the fully paid up shares is 4 fully paid up shares for 25 ordinary shares held on the record date. The rights entitlement ratio for the partially paid-up shares is 2 fully paid up shares for 25 ordinary shares held on the record date.

The record date for the issue is February 1, 2018. The issue would open on February 14, 2018, and close on February 28, 2018. On December 19, 2018, the Board of Directors of Tata Steel had approved the raising of capital via rights issue as well as a 5 mtpa expansion to the Kalinganagar steel plant. Currently, the Kalinganagar steel plant has a capacity of 3mtpa and had a utilization level of 100% for Q3FY18.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

TOP CORPORATE NEWS - 29 JULY 2016

                                      
Vedanta Q1: Cons Net Profit -30.4% at Rs615 Cr Vs Rs884 Cr (YoY)

Vedanta Q1: Cons Net Profit -30.4% at Rs615 Cr Vs Rs884 Cr (YoY)

Cons Total Income -15.1% at Rs14, 437 Cr Vs Rs17, 009 Cr (YoY)

Cons EBITDA -15.8% at Rs3, 439.6 Cr Vs Rs4, 087.2 Cr (YoY).

Pidilite Q1: Net Profit +16.1% at Rs272 Cr Vs Rs234.3 Cr (YoY)

Pidilite Q1: Net Profit +16.1% at Rs272 Cr Vs Rs234.3 Cr (YoY)

Total Income +8.6% at Rs1, 692 Cr Vs Rs1, 557.4 Cr (YoY)

Other Income at Rs24.1 Cr Vs Rs13.9 Cr (YoY)

EBITDA +15.2% at Rs394.4 Cr Vs Rs342.3 Cr (YoY)

EBITDA Margin at 23.3% Vs 22% (YoY)

Alembic Pharma Q1 consolidated net profit up 45% (YoY)

Alembic Pharmaceuticals has announced the following Q1 results for the quarter ended June 30, 2016:

Standalone

Net Profit rose by 53.21% to Rs119.74 crore Vs Rs78.15 crore (YoY).

Total Income increased by 20.01% to Rs688.98 crore Vs Rs574.10 (YoY).

Karnataka Bank Q1 net profit up 11% (YoY)

Karnataka Bank Ltd has announced the following Unaudited Standalone results for the quarter ended June 30, 2016:

Net Profit rose by 11.15% to Rs121.54 crore Vs Rs109.34 crore (YoY).

Total Income increased by 6.43% to Rs1434.96 crore Vs Rs1348.17 crore (YoY).

Kesoram plans Rs600 crore capex for tyre, cement divisions

Kesoram Industries is planning to spend around Rs600 crore on capital expenditure in FY2017.

The company has lined up an investments of Rs350 crore for strengthening its tyre business while about Rs250 crore will be pumped in for its cement division.

The Rs600 crore capex would be over and above the Rs500 crore that was already booked for work-in-progress.

Get real time advice for  Intraday Trading Tips , Intraday Market Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips  , Equity Tips  and all Maket Updates From Capitalstars .

NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS - 03 JUN 2016

CS NIFTY FUTURES (JUNE) OVERVIEW

TREND MIXED TO BULLISH

RES2:8295

RES 1:8255     

SUP1:8155

SUP2:8115

CS BANK NIFTY FUTURES (JUNE) OVERVIEW

TREND MIXED TO BULLISH

RES 2:17755

RES 1:17675

SUP1:17325

SUP2:17275

                                                  

Get real time advice for Intraday Trading Tips , Share Market Tips  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

Top 5 Things to Know In the Market on Thursday

Here are the top five things you need to know in financial markets on Thursday, June 2:

1. OPEC meets in Vienna
The Organization of the Petroleum Exporting Countries’ closely-monitored meeting kicked off in Vienna at 08:00GMT, or 4:00AM ET. The oil cartel is due to release a statement following the conclusion of the summit at around 14:00GMT, or 10:00AM ET, although no dramatic announcement on a production cut is expected.
Speaking to journalists ahead of the meeting, Saudi Arabia’s oil minister, Khalid Al-Falih, said the oil group’s strategy of letting the market rebalance itself out on its own appeared to be working.
Brent was up 25 cents, or 0.5%, at $49.97 a barrel by 9:55GMT, or 5:55AM ET, after rising to a high of $50.30, while U.S. crude tacked on 20 cents, or 0.4%, to $49.21.
Traders will also eye weekly government stockpile data from the U.S. due at 15:00GMT, or 11:00AM ET, amid expectations for a drop of 2.5 million barrels.

2. ECB policy decision, Draghi in focus
The European Central Bank's interest rate decision is due at 11:45GMT, or 7:45AM ET, with most of the focus likely to be on President Mario Draghi's press conference 45 minutes after the announcement. The consensus is that the ECB will stand pat on rates and reaffirm its focus on implementing the stimulus package announced in March.
The ECB will also release updated inflation and growth forecasts, with some analysts expecting the bank to raise its projections for inflation and growth.

3. U.S. employment data due ahead of the bell
The U.S. was to release the ADP jobs report for May at 12:15GMT, or 8:15AM ET, followed by weekly jobless claims data at 12:30GMT, or 8:30AM ET.
Market players are also focusing on Friday's U.S. nonfarm payrolls report. The consensus forecast is that the data will show jobs growth of 162,000 last month, following an increase of 160,000 in April, the unemployment rate is forecast to dip to 4.9%, while average hourly earnings are expected to rise 0.2% after gaining 0.3% a month earlier.
Solid readings could further heighten expectations for a move as soon as the Federal Reserve's next policy meeting on June 14-15.
Traders are now pricing in a 20% chance for a rate hike in June and 58% in July, according to CME Group's (NASDAQ:CME) FedWatch tool. September odds were at about 66%.

4. Global stocks mostly higher ahead of key risk events
U.S. stock futures pointed to a flat open on Thursday, as market players looked ahead to key U.S. data later in the day for more clues on the Federal Reserve’s next move.
Elsewhere, European stock markets were marginally higher, as investors waited to hear about monetary policy from the European Central Bank and oil output policy from the Organization of the Petroleum Exporting Countries.
Earlier, Japan's Nikkei tumbled 2% after the government moved to delay a sales-tax hike for more than two years, bucking mostly higher markets around the region.

5. Dollar moves further away from 2-month highs
The U.S. dollar retreated further from a two-month high against a basket of major currencies early Thursday. The dollar index was down 0.15% at 95.28, moving further away from Monday’s two-month peak of 95.96.

The greenback fell to a two-week low of 108.84 against the yen and was last down 0.5% at 109.01 (USD/JPY), while the euro touched a two-week peak of 1.1220 and last traded at 1.1202, up 0.1% (EUR/USD).

                                             

Get real time advice for Intraday Trading Tips , Share Market Tips  , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates . 

CAPITAL STARS PERFORMANCE MESSAGE

CS PERFORMANCE MESSAGE

BULLION  INTRADAY: CapitalStars

CRUDE OIL APRIL BUY CAL : 3^RD TG ACHIEVED

ALUMINIUM APRIL BUY CALL : 1^ST TG ACHIEVED

LEAD APRIL BUY CALL : SL TRIGGERED

AGRI  INTRADAY: CapitalStars

CHANA  MAY  BUY CALL : 1^ST TG ACHIEVED

AGRI PREMIUM : CapitalStars

JEERA MAY BUY CALL : SL TRIGGERED 

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market CapitalStars specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX.

For Any Query Feel Free to Contact Us... 9977499927 or visit www.capitalstars.com

AGRI COMMODITY MARKET UPDATES 15-04-2015

COMMODITY : CAPITALSTARS

CS TURMERIC   (MAY) OVERVIEW: CAPITALSTARS
TREND MIXED TO BEARISH
RESIST 2:8990
RESIST 1:8760                
SUP1:8390
SUP2:8250
STRATEGY: SELL ON RISE
WWW.CAPITALSTARS.COM +917316790000

CS SOYABEAN (JUNE) OVERVIEW: CAPITALSTARS
TREND MIXED TO BULLISH
RESIST 2:3775
RESIST 1:3735
SUP1:3635
SUP2:3575
STRATEGY: BUY ON DIPS
WWW.CAPITALSTARS.COM +917316790000

CS CHANA  (MAY) OVERVIEW: CAPITALSTARS                      
TREND  MIXED TO BULLISH
RESIST 2:4100
RESIST 1:4050
SUP1:3950
SUP2:3900
STRATEGY: BUY ON DIPS
WWW.CAPITALSTARS.COM +917316790000

CS DHANIYA (MAY) OVERVIEW: CAPITALSTARS
TREND  MIXED TO BEARISH
RESIST 2:9590
RESIST 1: 9425             
SUP1:9130
SUP2:9000      
STRATEGY: SELL ON RISE
WWW.CAPITALSTARS.COM +917316790000

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market CapitalStars specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX.

For Any Query Feel Free to Contact Us... 9977499927 or visit www.capitalstars.com